Cancer de la vessie (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cancer de la vessie" in French language version.

refsWebsite

Global rank French rank

6sciencedirect.com

149^th place

80^th place

4auajournals.org

low place

low place

4^th place

12^th place

3jamanetwork.com

2,650^th place

689^th place

low place

7,741^st place

1,684^th place

6,412^th place

222^nd place

129^th place

1,226^th place

347^th place

1frontiersin.org

4,679^th place

1,649^th place

low place

low place

1aacrjournals.org

8,869^th place

4,895^th place

2,769^th place

931^st place

1oxfordjournals.org

1,389^th place

508^th place

low place

low place

2,393^rd place

506^th place

low place

low place

low place

low place

1jcojournal.org

low place

low place

4,025^th place

1,224^th place

aacrjournals.org

clincancerres.aacrjournals.org

(en) Chow NH, Chan SH, Tzai TS et al. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder, Clin. Cancer Res., 2001;7:1957-1962

amjpathol.org

ajp.amjpathol.org

(en) Urist MJ, Di Como CJ, Lu M-L et al. Loss of p63 expression is associated with tumor progression in bladder cancer, Am J Pathol, 2002;161:1199-1206

ascopubs.org

ascopubs.org

Balar AV, Kulkarni GS, Uchio EM et al. Keynote 057: phase II trial of pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG), J Clin Oncol, 2019;37(suppl7):350

jco.ascopubs.org

Bellmunt J, Theodore C, Demkov T, et al . Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. J Clin Oncol 2009;27:4454-4461.

auajournals.org

Chang SS, Bochner BH, Chou R et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline, J Urol, 2017;198:552-559
Sylvester RJ, van der Meijden APM, Witjes JA, Kurth K, Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials, J Urol, 2005;174:86-91
Steinberg G, Bahnson R, Brosman S et al. Efficacy and safety of valrubicin for the treatment of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder, J Urol, 2000;163:761-767
Steinberg RL, Thomas LJ, Brook N et al. Multi-institution evaluation of sequential gemcitabine and docetaxel as rescue therapy for nonmuscle invasive bladder cancer, J Urol, 2020;203:902-909

bmj.com

Wallis CJD, Mahar AL, Choo R et al. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis, BMJ, 2016;352:i851

cancer.gov

seer.cancer.gov

(en) « Cancer of the Urinary Bladder » (consulté le 18 juin 2015)

frontiersin.org

Ishida K, Hsieh MH, Understanding urogenital schistosomiasis-related bladder cancer: an update, Front Med (Lausanne), 2018;5:223

iarc.fr

Centre international de recherche sur le cancer - Simple urine test could significantly improve early detection of bladder cancer, say researchers

jamanetwork.com

Richters A, Aben KKH, Kiemeney LALM, The global burden of urinary bladder cancer: an update, World J Urol, 2020;38:1895-1904
Lenis AT, Lec PM, Chamie K et al. Bladder Cancer: A Review, JAMA, 2020;324:1980-1991
Messing EM, Tangen CM, Lerner SP et al. Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial, JAMA, 2018;319:1880-1888

jcojournal.org

Moore, Malcolm J., Winquist, Eric W., Murray, Nevin, Tannock, Ian F., Huan, Susan, Bennett, Katherine, Walsh, Wendy, Seymour, Lesley Gemcitabine Plus Cisplatin, an Active Regimen in Advanced Urothelial Cancer: A Phase II Trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 1999 17: 2876

jurology.com

Sylvester RJ, Oosterlinck W, van der Meijden AP, A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials, J Urol, 2004;171:2186-2190

lww.com

journals.lww.com

Lim A, Rao P, Matin SF, Lynch syndrome and urologic malignancies: a contemporary review, Curr Opin Urol, 2019;29:357-363

nih.gov

pubmedcentral.nih.gov

(en) Lamm SH, Engel A, Penn CA et al. Arsenic cancer risk confounder in southwest Taiwan data set, Environ Health Perspect, 2006;114:1077-1082

ncbi.nlm.nih.gov

(en) Water disinfection by-products and bladder cancer

ehp03.niehs.nih.gov

(en) Pooling Data on Pools : Genotoxicity of Chemicals in Indoor Swimming Pools

pubmed.ncbi.nlm.nih.gov

Edwards TJ, Dickinson AJ, Natale S et al. A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic, BJU Int, 2006;97:301-305

oxfordjournals.org

aje.oxfordjournals.org

(en) Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools

rsnajnls.org

radiology.rsnajnls.org

(en) Deserno WM, Harisinghani MG, Taupitz M, Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging, Radiology, 2004;233:499-556

sciencedirect.com

Dobruch J, Daneshmand S, Fisch M et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes; Eur Urol, 2016;69:300-310
Colin, R., Grzebyk, M., Goutet, P., Hedelin, G., & Bourgkard, E. (2017). Cancer de la vessie et expositions professionnelles aux brouillards d’huiles: étude cas–témoins nichée dans une cohorte de travailleurs de la sidérurgie. Revue d'Épidémiologie et de Santé Publique, 65(1), 85-86 |résumé
Boulanger M, Tual S, Lemarchand C, Guizard A V, Velten M, Marcotullio E, ... & Lebailly P (2016) Expositions professionnelles en agriculture et risque de cancer de la vessie: résultats de la cohorte Agrican. Archives des Maladies Professionnelles et de l'Environnement, 77(3), 497 |résuméarsn.
Burger M, Grossman HB, Droller M et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data, Eur Urol, 2013;64:846-854
Varinot, J., Furudoï, A., Roupret, M., & Compérat, E. (2016). Mise au point sur les classifications moléculaires et la nouvelle classification histologique du cancer de la vessie . Progrès en Urologie, 26(11), 600-607 |résumé
Zargar H, Espiritu PN, Fairey AS et al. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer, Eur Urol, 2015;67:241-249

thelancet.com

(en) Kaufman DS, Shipley WU, Feldman AS, Bladder cancer, Lancet, 2009;374:239-249

uroweb.org

Babjuk M, Burger M, Comperat E et al. European Association of Urology non-muscle invasive bladder cancer guidelines, 2020

wiley.com

bjui-journals.onlinelibrary.wiley.com

Shariat SF, Sfakianos JP, Droller MJ et al. The effect of age and gender on bladder cancer: a critical review of the literature, BJU Int, 2010;105:300-308